Interferon-Stimulated Genes: Novel Targets in Renal Pathogenesis
Kidney Diseases · 02.05.2025 · 11 (1) · 390-401
DOI: 10.1159/000546141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney Diseases, online erschienen am 02.05.2025. Verfasst von Meng Jia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Kidney diseases are a prevalent global health concern, and despite ongoing research, there remains a lack of fully effective clinical treatments to prevent or halt their progression. Consequently, it is encouraged to identify novel biomarkers, establish early diagnostic methods, pinpoint key molecular pathways, and develop innovative therapeutic targets for more effective management of renal disorders. Summary: Interferons (IFNs), a group of cytokines, play pivotal roles in immune responses, particularly in antiviral and antiproliferative activities. IFNs trigger a cascade of signaling events that lead to the induction of interferon-stimulated genes (ISGs), which are essential for controlling viral infections and regulating immune responses. This review explores the impact of interferon-related genes on renal disorders, focusing on the mechanisms, therapeutic approaches, and consequences of enhanced interferon signaling in the kidney. Key Messages: Most diagnostic and therapeutic strategies targeting ISGs are still far from clinical implementation. The better understanding of ISG-regulated pathophysiology and the progress of new intervention approaches are expected to facilitate the clinical translation of ISGs-based diagnosis and therapy of kidney diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Division of Life Sciences and Medicine, Department of Phase I Clinical Trials Laboratory, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Zitieren
APA
Jia, M., Han, S., Li, L., Fu, Y., & Zhou, D. (2025). Interferon-Stimulated Genes: Novel Targets in Renal Pathogenesis. Kidney Diseases, 11(1), 390-401. https://doi.org/10.1159/000546141
Vancouver
Jia M, Han S, Li L, Fu Y, Zhou D. Interferon-Stimulated Genes: Novel Targets in Renal Pathogenesis. Kidney Diseases. 2025;11(1):390-401. doi:10.1159/000546141
BibTeX
@article{Jia2025,
author = {Jia, Meng and Han, Shuangxu and Li, Liang and Fu, Yi and Zhou, Di},
title = {Interferon-Stimulated Genes: Novel Targets in Renal Pathogenesis},
journal = {Kidney Diseases},
year = {2025},
volume = {11},
number = {1},
pages = {390--401},
doi = {10.1159/000546141}
}
EUVIMED